How can genetic markers help tailor treatment for people with drug-resistant multiple myeloma?
Summary
Description: Researchers at Oxford University have identified genetic markers which are common in drug-resistant multiple myeloma. Identifying these markers may enable clinicians to spot drug resistance and tailor treatment before the disease progresses, resulting in better clinical outcomes for patients.
